Aspergillus meningitis: Diagnosis by non-culture-based microbiological methods and management

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 1186-1189

  Verweij, Paul E ^a   Brinkman, Kees ^a,b   Kremer, Herbert P H ^a   Kullberg, Bart Jan ^a   Meis, Jacques F G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GALACTOMANNAN; IMMUNOGLOBULIN G ANTIBODY; VORICONAZOLE;

AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MENINGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

EID: 0033058427     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.1186-1189.1999     Document Type: Article

References (34)

1. Adunsky, A., E. Rubenstein, and A. Goldsmith. 1996. Aspergillus flavus meningitis and pontine hemorrhage in an older patient. J. Am. Geriatr. Soc. 44:739-740.
2. Atkinson, G. W., and H. L. Israel. 1973. 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis. Am. J. Med. 55:496-504.
3. Beal, M. F., C. P. O'Carroll, G. M. Kleinman, and R. I. Grossman. 1982. Aspergillosis of the nervous system. Neurology 32:473-479.
4. Camarata, P. J., D. L. Dunn, A. C. Farney, R. G. Parker, and E. L. Seljeskog. 1992. Continual intracavitary administration of amphotericin B as an adjunct in the treatment of aspergillus brain abscesses: case report and review of the literature. Neurosurgery 31:575-579.
5. Carnevale, N. T., J. N. Galgiani, D. A. Stevens, M. K. Herrick, and J. W. Langston. 1980. Amphotericin B-induced myelopathy. Arch. Intern. Med. 140:1189-1192.
6. Coleman, J. M., G. G. Hogg, J. V. Rosenfeld, and K. D. Waters. 1995. Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery - case report and review of the literature. Neurosurgery 36:858-863.
7. Denning, D., A. del Favero, E. Gluckman, D. Norfolk, M. Ruhnke, S. Yonren, P. Troke, and N. Sarantis. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis, abstr. F80, p. 126. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
8. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12:1147-1201.
9. Dickinson, R. P., A. S. Bell, C. A. Hitchcock, S. Narayanaswami, S. J. Ray, K. Richardson, and P. F. Troke. 1996. Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-YL)butan-2-OL derivatives with high activity against Aspergillus fumigatus. Bioorg. Med. Chem. Lett. 16:2031-2036.
10. Diengdoh, J. V., R. O. Barnard, and D. G. T. Thomas. 1983. Aspergillosis of the nervous system. Report of two cases. Neuropathol. Appl. Neurobiol. 9:477-484.
11. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
12. Gordon, M. A., R. S. Holzman, H. Senter, E. W. Lapa, and M. J. Kupersmith. 1976. Aspergillus oryzae meningitis. JAMA 235:2122-2123.
13. Kloss, S., A. Shuster, H. Schroten, J. Lamprecht, and V. Wahn. 1991. Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur. J. Pediatr. 150:483-485.
14. Lammens, M., W. Robberecht, M. Waer, H. Carton, and R. Dom. 1992. Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus. Clin. Neurol. Neurosurg. 94:39-43.
15. Louria, D. B. 1962. Experiences with and diagnosis of diseases due to opportunistic fungi. Ann. N. Y. Acad. Sci. 98:617-627.
16. McGinnis, M. R. 1983. Detection of fungi in cerebrospinal fluid. Am. J. Med. 75:129-138.
17. Melchers, W. J. G., P. E. Verweij, P. van den Hurk, A. van Belkum, B. E. De Pauw, J. A. A. Hoogkamp-Korstanje, and J. F. G. M. Meis. 1994. General primer-mediated PCR for detection of Aspergillus species. J. Clin. Microbiol. 32:1710-1717.
18. Mikolich, D. J., L. J. Kinsella, G. Skowron, J. Friedman, and A. M. Sugar. 1996. Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole. Clin. Infect. Dis. 23:1318-1319.
19. Mori, T., and T. Ebe. 1992. Analysis of cases of central nervous system fungal infections reported in Japan between January 1979 and June 1989. Intern. Med. 31:174-179.
20. Morrow, R., B. Wong, W. E. Finkelstein, S. S. Sternberg, and D. Armstrong. 1983. Aspergillosis of the cerebral ventricles in a heroin abuser. Case report and review of the literature. Arch. Intern. Med. 143:161-164.
21. Murai, H., J. Kira, T. Kobayashi, I. Goto, H. Inoue, and K. Hasuo. 1992. Hypertrophic cranial pachymeningitis due to Aspergillus flavus. Clin. Neurol. Neurosurg. 94:247-250.
22. Patterson, T. F., P. Miniter, J. E. Patterson, J. M. Rappeport, and V. T. Andriole. 1995. Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J. Infect. Dis. 171:1553-1558.
23. Peacock, J. E. 1990. Persistent neutrophilic meningitis. Infect. Dis. Clin. N. Am. 4:747-767.
24. Perfect, J. R., and D. T. Durack. 1985. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J. Antimicrob. Chemother. 16:81-86.
25. Prentice, A. G., and D. W. Warnock. 1996. Itraconazole more bioavailable in solution. Blood 9:662-663.
26. Ray, P., A. Chakrabarti, M. Jatana, B. S. Sharma, and A. Pathak. 1995. Western blot analysis of cerebrospinal fluid for detection of Aspergillus antigens. Mycopathologia 131:103-106.
27. Sanchéz, C., E. Mauri, D. Dalmau, S. Quintana, A. Aparicio, and J. Garau. 1995. Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? Clin. Infect. Dis. 21:1485-1487.
28. Schwartz, S., D. Milatovic, and E. Thiel. 1997. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukemia. Br. J. Haematol. 97:663-665.
29. Stein, S. C., M. L. Corrado, M. Friedlander, and P. Farmer. 1982. Chronic mycotic meningitis with spinal involvement (arachnoiditis): a report of five cases. Ann. Neurol. 11:519-524.
30. Stynen, D., A. Goris, J. Sarfati, and J. P. Latgé. 1995. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. 33:497-500.
31. Van de Wyngaert, F. A., C. J. M. Sindic, J. J. Rousseau, F. G. Fernandes Xavier, J. M. Brucher, and E. C. Laterre. 1986. Spinal arachnoiditis due to Aspergillus meningitis in a previously healthy patient. J. Neurol. 233:41-43.
32. Verweij, P. E., J. F. G. M. Meis, P. Van Den Hurk, B. E. De Pauw, J. A. A. Hoogkamp-Korstanje, and W. J. G. Melchers. 1994. Polymerase chain reaction as a diagnostic tool for invasive aspergillosis: evaluation in bronchoalveolar lavage fluid from low risk patients. Serodiagn. Immunother. Infect. Dis. 6:203-208.
33. Verweij, P. E., E. C. Dompeling, J. P. Donnelly, A. V. M. B. Schattenberg, and J. F. G. M. Meis. 1997. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 25:86-59.
34. Weiner, M., R. Fetchick, J. Peacock, S. Foshee, L. Corman, M. Cohen, and P. Koym. 1984. Fungal meningitis: immunodiagnosis by detection of candidal and aspergillus antigens in cerebrospinal fluid, abstr. 1096, p. 285. In Program and abstracts of the Twenty-Fourth Interscience Conference on Anti-microbial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.